investment

Medtech firm plans clinical trials following €6.7 million investment

Versono’s Fastwire intravascular device is designed to allow doctors get through the most difficult blockages they find in arteries

Finbar Dolan, chief executive, Versono: ‘The investment means we’ll be able to get the product out in front of a large community of doctors and start that process of commercialisation’